Salute e Benessere
Global Heart Closure Devices Market to Witness Upsurge in Growth at a CAGR of ~7% by 2030 | DelveInsight
To read more about the latest highlights related to the heart closure devices market, get a snapshot of the key highlights entailed in the
Heart closure devices are medical tools designed to treat structural defects in the heart, such as atrial septal defects (ASD), patent foramen ovale (PFO), and ventricular septal defects (VSD). These devices are typically small, mesh-like structures made of metal and synthetic materials. They are deployed via a minimally invasive procedure known as cardiac catheterization, where the device is guided through blood vessels to the heart using a catheter. Once in place, the device expands to cover and seal the defect, promoting tissue growth over time that fully closes the opening. This method reduces the need for open-heart surgery, decreasing recovery times and associated risks.
The development and utilization of heart closure devices have significantly improved the prognosis for patients with congenital heart defects. These devices not only mitigate symptoms such as fatigue, breathlessness, and stroke risk but also enhance overall heart function. Innovations in this field continue to evolve, with newer devices becoming more effective and easier to implant. Clinical trials and long-term studies have demonstrated the safety and efficacy of heart closure devices, making them a standard treatment option. As technology advances, these devices will likely become even more refined, offering hope and a better quality of life for patients with heart defects.
In 2023, North America held the largest share of the heart closure devices market. This is attributed to several key factors: a rise in congenital heart defects among children, increasing awareness programs and initiatives for children with cardiac abnormalities, high disposable income, advanced healthcare infrastructure, the presence of key market players, and heightened product development activities. These elements are expected to drive market growth in the region from 2024 to 2030.
According to the Centers for Disease Control and Prevention (CDC) in 2023, congenital heart defects (CHDs) affect nearly 1% of births in the United States , equating to about 40,000 births per year. Every 15 minutes, a baby is born with a congenital heart defect in the U.S.
The CDC also reports that over 2.4 million children and adults in the U.S. currently live with congenital heart defects. Annually, approximately 5,240 babies in the U.S. are born with an atrial septal defect, representing about 1 in every 769 births. Additionally, around 16,800 babies are born each year with a ventricular septal defect, or 1 in every 240 births.
The increase in product approvals and launches further supports market growth. For example, in September 2023 , the FDA approved the WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device by Boston Scientific Corporation.
These factors are anticipated to drive the growth of the heart closure devices market in North America during the forecast period from 2024 to 2030.
To know more about why North America is leading the market growth in the heart closure devices market, get a snapshot of the
The heart closure devices market has experienced significant growth in recent years, driven by and an . These devices, which include products like septal occluders, left atrial appendage closure devices, and patent foramen ovale (PFO) closure devices, are essential in the minimally invasive treatment of congenital heart defects and in the . The of heart-related conditions, particularly in aging populations, has propelled the demand for , thereby boosting the market for heart closure devices.
Technological innovations have been pivotal in shaping the heart closure devices market. The with enhanced precision, safety, and ease of use has broadened the scope of procedures that can be performed percutaneously. For instance, have improved the accuracy of device placement, minimizing risks and improving patient outcomes. Additionally, the has reduced the incidence of complications such as device-related thrombosis or infection, further driving the adoption of these devices in clinical practice.
for the use of heart closure devices have also contributed to market growth. The FDA and other regulatory bodies worldwide have approved several devices for broader applications, including who are contraindicated for anticoagulant therapy. These approvals not only validate the safety and efficacy of the devices but also open up new patient segments, thereby expanding the market. Furthermore, in many countries are making these procedures more accessible, encouraging both patients and healthcare providers to opt for these advanced treatments.
Market dynamics are also influenced by the competitive landscape, characterized by the . Major companies like Abbott Laboratories, Boston Scientific Corporation, and W.L. Gore & Associates are at the forefront, investing heavily in research and development to innovate and expand their product portfolios. are common, aiming to leverage each other's strengths and accelerate the introduction of new products. This competitive environment fosters innovation and drives down costs, making heart closure devices more affordable and widely available.
However, the market does face challenges, including . Despite these hurdles, the overall outlook for the heart closure devices market remains positive. Continuous technological advancements, increasing awareness about minimally invasive procedures, and growing healthcare expenditure are expected to sustain the market's growth trajectory. As the global burden of cardiovascular diseases continues to rise, the demand for effective heart closure solutions will likely remain strong, driving further innovations and market expansion.
Get a sneak peek at the heart closure devices market dynamics @
Which MedTech key players in the heart closure devices market are set to emerge as the trendsetter explore @
Interested in knowing the heart closure devices market by 2030? Click to get a snapshot of the
report delivers an in-depth understanding of market trends, market drivers, market barriers, and key PFO closure devices companies, including among others.
report delivers an in-depth understanding of market trends, market drivers, market barriers, and key left atrial appendage closure devices companies, including among others.
report delivers an in-depth understanding of market trends, market drivers, market barriers, and key arteriotomy closure devices companies, including among others.
report delivers an in-depth understanding of market trends, market drivers, market barriers, and key sternal closure devices companies, including among others.
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Shruti Thakur
info@delveinsight.com
+14699457679
https://www.delveinsight.com/medical-devices
Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/global-heart-closure-devices-market-to-witness-upsurge-in-growth-at-a-cagr-of-7-by-2030--delveinsight-302231189.html